Reports Q2 adjusted revenue $763.5 M, consensus $764.56M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TFX:
- Teleflex Announces Quarterly Dividend
- Teleflex Expands Interventional Cardiology Portfolio with FDA 510(k) Clearance of the Ringer™ Perfusion Balloon Catheter
- Teleflex (TFX) Q2 Earnings Cheat Sheet
- Teleflex awarded Hemostasis Products agreements with Premier
- Teleflex Awarded Hemostasis Products Agreements with Premier, Inc.